Name: BridgeBio Oncology Therapeutics, Inc. (BBOT) Balance Sheet
Creator: FinSpry

BridgeBio Oncology Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for BridgeBio Oncology Therapeutics, Inc. (BBOT) - Annual data in millions USD
Breakdown	FY 2024	FY 2023
Period Ending	Dec 2024	Dec 2023
Current Assets
Cash and Cash Equivalents	1.70	0.25
Cash & Short-Term Investments	1.70	0.25
Accounts Receivable	0.00	1.72
Inventory	0.00	0.00
Other Current Assets	0.25	1.96
Total Current Assets	1.95	3.94
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.60
Long-Term Investments	192.45	0.00
Other Non-Current Assets	0.03	1.41
Total Non-Current Assets	192.47	2.01
Total Assets	194.42	5.94
Current Liabilities
Accounts Payable	0.00	0.58
Accrued Liabilities	9.10	3.54
Other Current Liabilities	0.19	12.66
Total Current Liabilities	0.19	16.78
Non-Current Liabilities
Long-Term Debt	0.00	0.00
Other Non-Current Liabilities	5.52	0.00
Total Non-Current Liabilities	5.52	104.81
Total Liabilities	5.71	16.78
Stockholders' Equity
Common Stock	192.45	0.00
Retained Earnings	-3.73	-148.25
Accumulated Other Comprehensive Income	0.35	0.00
Additional Paid-in Capital	43.54	32.61
Shares Outstanding	79.20	79.20
Total Stockholders' Equity	188.72	-10.83
Total Liabilities & Equity	194.42	5.94